Keyphrases
Activity Level
40%
Biochemical Assessment
100%
Brain Tissue
20%
Canine Model
20%
Early Treatment
20%
Effective Treatment
20%
Enzyme Replacement Therapy
100%
Fusion Protein
20%
Heparan Sulfate
40%
Insulin-like Growth Factor 2 (IGF2)
100%
Liver
20%
Liver Tissue
20%
Mouse Model
20%
MPS IIIB
100%
Mucopolysaccharidosis IIIB
20%
N-acetylglucosaminidase
60%
Neonatal Mice
100%
Neurological Deterioration
20%
Potential Gains
20%
Sanfilippo Syndrome
100%
Therapeutic Effect
20%
β-hexosaminidase
40%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylglucosaminidase
100%
Beta N Acetylhexosaminidase
66%
Canine Model
33%
Chimeric Protein
33%
Heparan Sulfate
66%
Mouse Model
33%
Mucopolysaccharidosis
33%
Preclinical Study
33%
Replacement Therapy
100%
Sanfilippo Syndrome
33%
Syndrome
100%
Therapeutic Effect
33%
Medicine and Dentistry
Acetylglucosaminidase
100%
Beta N Acetylhexosaminidase
66%
Brain Tissue
33%
Chimeric Protein
33%
Clinical Study
33%
Enzyme Replacement Therapy
100%
Heparan Sulfate
66%
Lifespan
33%
Liver Tissue
33%
Mucopolysaccharidosis
33%
Sanfilippo Syndrome
33%
Single Drug Dose
66%
Therapy Effect
33%